Diasorin SpA (STU:34D) Total Liabilities : €1,511 Mil (As of Jun. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Total Liabilities?

Diasorin SpA's Total Liabilities for the quarter that ended in Jun. 2024 was €1,511 Mil.

Diasorin SpA's quarterly Total Liabilities declined from Dec. 2023 (€1,673.47 Mil) to Mar. 2024 (€0.00 Mil) but then increased from Mar. 2024 (€0.00 Mil) to Jun. 2024 (€1,510.70 Mil).

Diasorin SpA's annual Total Liabilities increased from Dec. 2021 (€1,863.21 Mil) to Dec. 2022 (€1,888.33 Mil) but then declined from Dec. 2022 (€1,888.33 Mil) to Dec. 2023 (€1,673.47 Mil).

Diasorin SpA Total Liabilities Historical Data

The historical data trend for Diasorin SpA's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Total Liabilities Chart

Diasorin SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

214.93

290.13

1,863.21

1,888.33

1,673.47

Diasorin SpA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															-	1,673.47	-	1,510.70	-

Diasorin SpA Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Diasorin SpA's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	320.117	+	(1083.006	+	238.034
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	32.314)
	=	1,673

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3211.439	-	1537.968
	=	1,673

Diasorin SpA's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	266.37	+	(969.509	+	242.497
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	32.324)
	=	1,511

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	3125.513	-	1614.813
	=	1,511

Diasorin SpA Total Liabilities Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (STU:34D) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

DIA:Italy DIAm:UK 0GZX:UK DIAS:Austria

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines